Advertisement

Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode

      Abstract

      In diabetics with coronary artery disease (CAD), there remains uncertainty as to whether revascularization by percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass surgery (CABG) is preferable. To address this, 4-year mortality and level of pre- and postrevascularization angiographic CAD (measured by a series of coronary scores) were compared between both diabetics and nondiabetics and between revascularization modes in the Coronary Angioplasty versus Bypass Revascularization Investigation population as a whole, and then substratified by diabetic status and then by procedure to which they were randomized. The 1,054 randomized subjects contained 125 diabetics (11.9%) who had significantly greater mortality than nondiabetics (RR 2.19, p = 0.001). Among diabetics or nondiabetics, there was no significant mortality difference between those randomized to PTCA versus those to CABG. Diabetics randomized to PTCA and those to CABG had higher mortalities than respective nondiabetics; the association reached significance only in the former (RR 2.41, p = 0.002). All subgroups had similar prerevascularization CAD. Postrevascularization residual CAD was consistently significantly greater in PTCA than in respective CABG subgroups. Most measurements of CAD were greater in diabetic than in nondiabetic subgroups, but none was significant. In the Coronary Angioplasty versus Bypass Revascularization Investigation, diabetics had double the mortality of nondiabetics; this difference was statistically significant both for the entire population and for those randomized to PTCA, but not for those randomized to CABG. Among diabetics or nondiabetics, there was no significant mortality difference between PTCA and CABG. The higher diabetic mortality was more likely related to more rapid disease progression than to greater postrevascularization disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jones E.L
        • Weintraub W.S
        • Craver J.M
        • Guyton R.A
        • Cohen C.L
        Coronary bypass surgery.
        J Thorac Cardiovasc Surg. 1991; 101: 108-115
        • Stein B
        • Weintraub W.S
        • Gebhart S.P
        • Cohen-Bernstein C.L
        • Grosswald R
        • Liberman H.A
        • Douglas Jr, J.S
        • Morris D.C
        • King III, S
        Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.
        Circulation. 1995; 91: 979-989
        • Kip K.E
        • Faxon D.P
        • Detre K.M
        • Yeh W
        • Kelsey S.F
        • Currier J.W
        Coronary angioplasty in diabetic patients.
        Circulation. 1996; 94: 1818-1825
        • CABRI Trial Participants
        First year results of CABRI (Coronary Angioplasty vs Bypass Revascularisation Investigation).
        Lancet. 1995; 346: 1179-1184
        • Bypass Angioplasty Revascularisation (BARI) Investigators
        Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
        N Engl J Med. 1996; 335: 217-225
        • King S.B
        • Lembo N.J
        • Weintraub W.S
        • Kosinski A.S
        • Barhart H.X
        • Kutner M.H
        • Alazraki N.P
        • Guyton R.A
        • Zhao X.Q
        A randomized trial comparing coronary angioplasty with coronary bypass surgery (EAST).
        N Engl J Med. 1994; 331: 1044-1050
        • RITA Trial Participants
        Coronary angioplasty versus coronary artery bypass surgery.
        Lancet. 1993; 343: 573-580
        • O’Keefe J.H
        • Blackstone E.H
        • Sergeant P
        • McCallister B.D
        The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery.
        Eur Heart J. 1998; 19: 1696-1703
        • Thourani V.H
        • Weintraub W.S
        • Stein B
        • Gebhart S.S
        • Craver J.M
        • Jones E.L
        • Guyton R.A
        Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.
        Ann Thorac Surg. 1999; 67: 1045-1052
        • Austen W.G
        • Edwards J.E
        • Frye R.L
        • Gensini G.G
        • Gott V.L
        • Griffith L.S
        • McGoon D.C
        • Murphy M.L
        • Roe B.B
        A reporting system on patients evaluated for CAD. Report of the Ad hoc Committee for Grading of Coronary Artery Disease, council on Cardiovascular Surgery, American Heart Association.
        Circulation. 1975; 51: 5-40
        • Leaman D.M
        • Brower R.W
        • Meester G.T
        • Serruys P
        • van den Brand M
        Coronary artery atherosclerosis.
        Circulation. 1981; 63: 285-291
        • Jones R.H
        • Kesler K
        • Phillips III, H.R
        • Mark D.B
        • Smith P.K
        • Nelson C.L
        • Newman M.F
        • Reeves J.G
        • Anderson R.W
        • Califf R.M
        Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with CAD.
        J Thorac Cardiovasc Surg. 1996; 111: 1013-1025
        • Reeder G.S
        • Holmes D.R
        • Detre K
        • Costigan T
        • Kelsy S.F
        Degree of revascularization in patients with patients with multivessel CAD.
        Circulation. 1988; 77: 638-644
        • Bell M.R
        • Bailey K.R
        • Reeder G.S
        • Lapeyre A.C
        • Holmes D.R
        Percutaneous transluminal angioplasty in patients with multivessel CAD.
        J Am Coll Cardiol. 1990; 16: 553-562
        • Kurbaan A.S
        • Bowker T.J
        • Ilsley C.D.J
        • Rickards A.F
        • CABRI investigators
        The impact of postangioplasty restenosis on comparisons of outcome between angioplasty and bypass grafting.
        Am J Cardiol. 1998; 82: 272-276
        • Morris J
        • Smith R
        • Jones R
        • Glower D
        • Morris P
        • Muhlbaier L
        • Reves J
        • Rankin J
        Influence of diabetes and mammary artery grafting on survival after coronary bypass.
        Circulation. 1991; 84: III275-III283
        • Alderman E.L
        • Corley S.D
        • Fisher L.D
        • Chaitman B.R
        • Faxon D.P
        • Foster E.D
        • Killip T
        • Sosa J.A
        • Bourassa M.G
        • CASS Participating Investigators and Staff
        Five-year angiographic follow-up of factors associated with progression of CAD in the Coronary Artery Surgery Study (CASS).
        J Am Coll Cardiol. 1993; 22: 1141-1154
        • Barzilay J
        • Kronmal R
        • Bittner V
        • Eaker E
        • Evans C
        • Foster E
        Coronary artery disease and coronary artery bypass grafting in diabetic patients aged >65 years (report from the Coronary Artery Surgery Study [CASS] registry).
        Am J Cardiol. 1994; 74: 334-339
        • Behar S
        • Boyko V
        • Reicher-Reiss H
        • Goldbourt U
        Ten-year survival after acute myocardial infarction.
        Am Heart J. 1997; 133: 290-295
        • Loop F.D
        • Lytle B.W
        • Cosgrove D.M
        • Stewart R.W
        • Goormastic M
        • Williams G.W
        • Golding L.A.R
        • Gill C.C
        • Taylor P.C
        • Sheldon W.C
        • Proudfit W.C
        Influence of the internal mammary artery on 10 year survival and other cardiac events.
        N Engl J Med. 1986; 314: 1-9
        • Chaitman B.R
        • Rosen A.D
        • Williams D.O
        • Bourassa M.G
        • Aguirre F.V
        • Pitt B
        • Rautaharju P.M
        • Rogers W.J
        • Sharaf B
        • Attubato M
        • Hardison R.M
        • Srivatsa S
        • Kouchoukos N.T
        • Stocke K
        • Sopko G
        • Detre K
        • Frye R
        Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial.
        Circulation. 1997; 96: 2162-2170
        • Henderson R.A
        • Pocock S.J
        • Sharp S.J
        • Nanchahal K
        • Schulpher M.J
        • Buxton M.J
        Long-term results of RITA-1 trial.
        Lancet. 1998; 352: 1419-1425
        • Barsness G.W
        • Peterson E.D
        • Ohman E.M
        • Nelson C.L
        • De Long E.R
        • Reves J.G
        • Smith P.K
        • Anderson R.D
        • Jones R.H
        • Mark D.B
        • Califf R.M
        Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.
        Circulation. 1997; 96: 2551-2556
        • Weintraub W.S
        • Stein B
        • Kosinski A
        • Douglas Jr, J.S
        • Ghazzal Z.M
        • Jones E.L
        • Morris D.C
        • Guyton R.A
        • Craver J.M
        • King III, S.B
        Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel CAD.
        J Am Coll Cardiol. 1998; 31: 10-19
        • Bourassa M.G
        • Roubin G.S
        • Detre K.M
        • Sopko G
        • Krone R.J
        • Attabuto M.J
        • Bjerregaad P
        • Bolling S
        • Herman M.V
        • Frye R
        • BARI study group
        Bypass angioplasty revascularization investigation.
        Am J Cardiol. 1995; 75: 3C-8C
        • Marso S.P
        • Lincoff A.M
        • Ellis S.G
        • Bhatt D.L
        • Tanguay J.F
        • Kleiman N.S
        • Hammoud T
        • Booth J.E
        • Sapp S.K
        • Topol E.J
        Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus.
        Circulation. 1999; 100: 2477-2484